These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25870183)

  • 21. National estimates of price variation by site of care.
    Higgins A; Veselovskiy G; Schinkel J
    Am J Manag Care; 2016 Mar; 22(3):e116-21. PubMed ID: 26978238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring Prices in Health Care Markets Using Commercial Claims Data.
    Neprash HT; Wallace J; Chernew ME; McWilliams JM
    Health Serv Res; 2015 Dec; 50(6):2037-47. PubMed ID: 25772745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Price And Low-Price Physician Practices Do Not Differ Significantly On Care Quality Or Efficiency.
    Roberts ET; Mehrotra A; McWilliams JM
    Health Aff (Millwood); 2017 May; 36(5):855-864. PubMed ID: 28461352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends In Medical And Pharmacy Spending In The Affordable Care Act Markets, 2015-19.
    Jacobson NG; Hansen D; Dieguez G
    Health Aff (Millwood); 2023 Feb; 42(2):277-285. PubMed ID: 36745828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of anesthesia services during outpatient endoscopies and colonoscopies and associated spending in 2003-2009.
    Liu H; Waxman DA; Main R; Mattke S
    JAMA; 2012 Mar; 307(11):1178-84. PubMed ID: 22436958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Reference Payment for Colonoscopy With Consumer Choices, Insurer Spending, and Procedural Complications.
    Robinson JC; Brown TT; Whaley C; Finlayson E
    JAMA Intern Med; 2015 Nov; 175(11):1783-9. PubMed ID: 26348851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in Colonoscopy Quality Among Facilities: Development of a Post-Colonoscopy Risk-Standardized Rate of Unplanned Hospital Visits.
    Ranasinghe I; Parzynski CS; Searfoss R; Montague J; Lin Z; Allen J; Vender R; Bhat K; Ross JS; Bernheim S; Krumholz HM; Drye EE
    Gastroenterology; 2016 Jan; 150(1):103-13. PubMed ID: 26404952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing different methods of indexing commercial health care prices.
    Johnson WC; Kennedy K
    Health Serv Res; 2020 Feb; 55(1):113-118. PubMed ID: 31763686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managed care discounting: evidence from the MarketScan database.
    Dor A; Koroukian SM; Grossman M
    Inquiry; 2004; 41(2):159-69. PubMed ID: 15449431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. THE PRICE AIN'T RIGHT? HOSPITAL PRICES AND HEALTH SPENDING ON THE PRIVATELY INSURED.
    Cooper Z; Craig SV; Gaynor M; Van Reenen J
    Q J Econ; 2019 Feb; 134(1):51-107. PubMed ID: 32981974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of health care price transparency on price variation: the New Hampshire experience.
    Tu HT; Lauer JR
    Issue Brief Cent Stud Health Syst Change; 2009 Nov; (128):1-4. PubMed ID: 19908405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ambulatory Surgery Centers and Prices in Hospital Outpatient Departments.
    Carey K
    Med Care Res Rev; 2017 Apr; 74(2):236-248. PubMed ID: 26951624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Market competition, ownership, payment systems and the performance of health care providers - a panel study among Finnish occupational health services providers.
    Kankaanpää E; Linnosmaa I; Valtonen H
    Health Econ Policy Law; 2013 Oct; 8(4):477-510. PubMed ID: 23057868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Price transparency for MRIs increased use of less costly providers and triggered provider competition.
    Wu SJ; Sylwestrzak G; Shah C; DeVries A
    Health Aff (Millwood); 2014 Aug; 33(8):1391-8. PubMed ID: 25092841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New evidence on the impacts of cross-market hospital mergers on commercial prices and measures of quality.
    Arnold DR; King JS; Fulton BD; Montague AD; Gudiksen KL; Greaney TL; Scheffler RM
    Health Serv Res; 2024 Apr; ():. PubMed ID: 38652542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospital prices and market structure in the hospital and insurance industries.
    Moriya AS; Vogt WB; Gaynor M
    Health Econ Policy Law; 2010 Oct; 5(4):459-79. PubMed ID: 20478106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Availability of a Price Transparency Tool and Outpatient Spending.
    Desai S; Hatfield LA; Hicks AL; Chernew ME; Mehrotra A
    JAMA; 2016 May; 315(17):1874-81. PubMed ID: 27139060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competition in Outpatient Procedure Markets.
    Baker LC; Bundorf MK; Kessler DP
    Med Care; 2019 Jan; 57(1):36-41. PubMed ID: 30507654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of physician and health plan market concentration on prices in commercial health insurance markets.
    Schneider JE; Li P; Klepser DG; Peterson NA; Brown TT; Scheffler RM
    Int J Health Care Finance Econ; 2008 Mar; 8(1):13-26. PubMed ID: 18038246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Market competition and price of disease management programmes: an observational study.
    van Dijk CE; Venema B; de Jong JD; de Bakker DH
    BMC Health Serv Res; 2014 Oct; 14():510. PubMed ID: 25359224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.